Somru BioScience is Biotechnology in Canada that focus on immunoassay products business. Founded in 2012. They cover business area such as owner, operator, antibody, immunoassay product, research, diagnostic and therapeutic application, generation, datum analysis, biocomparability testing service, cell signaling, receptor activation, ligand binding assay, client, life-save biotherapeutic.
2012
( 12 years old in 2024 )
Immunoassay Products
-
19 Innovation Way
BioCommons Research Park
Charlottetown, Prince Edward Island C1E 0B7
Canada
Private
owneroperatorantibodyimmunoassay productresearchdiagnostic and therapeutic applicationgenerationdatum analysisbiocomparability testing servicecell signalingreceptor activationligand binding assayclientlife-save biotherapeutic
* We use standard office opening hours in near Somru BioScience's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Somru BioScience is Biotechnology business from Canada that founded in 2012 (12 years old in 2024), Somru BioScience business is focusing on Immunoassay Products.
Somru BioScience headquarter office and corporate office address is located in 19 Innovation Way BioCommons Research Park Charlottetown, Prince Edward Island C1E 0B7 Canada.
Somru BioScience was founded in Canada.
In 2024, Somru BioScience is currently focus on immunoassay products sector.
Above is snippet of Google Trends for "immunoassay products" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Somru BioScience, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.